Intradiscal Regenerative Therapies: State of the Art
Dr. Annu Navani presents innovative intradiscal regenerative therapies for spinal pain localized to the low back or spinal discs. Dr. Navani discusses the current market for stem cell therapies and investments in regenerative medicine companies that are sponsoring various clinical trials worldwide.
Read More
She describes studies focusing on mesenchymal stem cells (MSCs) and explains the need for advances in regenerative medicine for clinical applications in pain management and tissue repair. Dr. Navani also discusses the first ever head-to-head multi-center, randomized, placebo-controlled trial comparing platelet-rich plasma (PRP) or bone marrow concentrate (BMC) against a placebo for discogenic back pain, followed by the projected growth of regenerative therapies.
Read Less
This experience is powered by CMEfy – an AI-powered platform that directs learners along a pathway to capture reflections at point of inspiration, point of care. Clinicians may earn CME/CE credit via ReflectCE, the accredited activity portal. Learn more at about.cmefy.com/cme-info
Comment
expand_more
expand_less